4//SEC Filing
Barlow Carrolee 4
Accession 0001628280-25-007179
CIK 0001356576other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:47 PM ET
Size
8.3 KB
Accession
0001628280-25-007179
Insider Transaction Report
Form 4
Barlow Carrolee
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-02-19+7,296→ 7,296 totalExercise: $33.52Exp: 2035-02-19→ Common Stock (7,296 underlying) - Award
Restricted Stock Unit
2025-02-19+4,475→ 4,475 total→ Common Stock (4,475 underlying)
Holdings
- 17,201
Common Stock
Footnotes (3)
- [F1]The option vests on February 19, 2026.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001745316
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:47 PM ET
- Size
- 8.3 KB